A 52-year-old woman experiences chronic GvHD post-stem cell transplant, showcasing skin and joint symptoms, requiring ongoing steroid management.
You will be redirected to our submission process. Cutaneous involvement account for the majority of drug-related adverse events. During recent years the introduction of novel and advanced target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results